These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports. Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370 [TBL] [Abstract][Full Text] [Related]
5. Amiodarone-induced torsades de pointes: the possible facilitatory role of digoxin. Bajaj BP; Baig MW; Perrins EJ Int J Cardiol; 1991 Nov; 33(2):335-7. PubMed ID: 1743800 [TBL] [Abstract][Full Text] [Related]
7. [Harmful interactions of amiodarone and class I anti-arrhythmia agents]. Tartini R; Kappenberger L; Steinbrunn W Schweiz Med Wochenschr; 1982 Nov; 112(45):1585-7. PubMed ID: 7156952 [TBL] [Abstract][Full Text] [Related]
8. Adverse reactions during treatment with amiodarone hydrochloride. McGovern B; Garan H; Kelly E; Ruskin JN Br Med J (Clin Res Ed); 1983 Jul; 287(6386):175-80. PubMed ID: 6409240 [TBL] [Abstract][Full Text] [Related]
10. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy. Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388 [TBL] [Abstract][Full Text] [Related]
11. Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia. Kuo CS; Reddy CP; Paciotti MV J Electrocardiol; 1985 Jan; 18(1):105-9. PubMed ID: 3882871 [TBL] [Abstract][Full Text] [Related]
12. Torsade de pointes after amiodarone withdrawal; effects of mild hypokalaemia on repolarization. Forfar JC; Gribbin B Eur Heart J; 1984 Jun; 5(6):510-2. PubMed ID: 6745293 [TBL] [Abstract][Full Text] [Related]
13. Amiodarone therapy for life threatening or refractory cardiac arrhythmias. Johns JA; Harper RW; Currie PJ; Federman J; Anderson ST; Pitt A Aust N Z J Med; 1983 Jun; 13(3):248-56. PubMed ID: 6579938 [TBL] [Abstract][Full Text] [Related]
14. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. Rowland E; Krikler DM Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165 [TBL] [Abstract][Full Text] [Related]
15. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone]. Makai A; Rudas L; Liszkai G; Fazekas T Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553 [TBL] [Abstract][Full Text] [Related]
16. QT prolongation and the antiarrhythmic efficacy of amiodarone. Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202 [TBL] [Abstract][Full Text] [Related]
17. Polymorphous ventricular tachycardia associated with a marked prolongation of the Q-T interval induced by amiodarone. Bhandari AK; Quock C; Sung RJ Pacing Clin Electrophysiol; 1984 May; 7(3 Pt 1):341-5. PubMed ID: 6204284 [TBL] [Abstract][Full Text] [Related]
18. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. Podrid PJ; Lown B Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665 [TBL] [Abstract][Full Text] [Related]
19. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias. Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121 [TBL] [Abstract][Full Text] [Related]